These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36786305)

  • 21. Brain natriuretic peptide as a predictor of delayed atrial fibrillation after ischaemic stroke and transient ischaemic attack.
    Okada Y; Shibazaki K; Kimura K; Iguchi Y; Miki T
    Eur J Neurol; 2010 Feb; 17(2):326-31. PubMed ID: 19845751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-terminal pro-brain natriuretic peptide level determined at different times identifies transient ischaemic attack patients with atrial fibrillation.
    Purroy F; Suárez-Luis I; Mauri-Capdevila G; Cambray S; Farré J; Sanahuja J; Piñol-Ripoll G; Quílez A; González-Mingot C; Begué R; Gil MI; Fernández E; Benabdelhak I
    Eur J Neurol; 2014 Apr; 21(4):679-83. PubMed ID: 23800180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative B-Type Natriuretic Peptides to Predict Postoperative Atrial Fibrillation in Cardiac Surgery: A Systematic Review and Meta-Analysis.
    Thet MS; Hlwar KE; Thet KS; Han KPP; Oo AY
    Heart Lung Circ; 2024 Jan; 33(1):23-32. PubMed ID: 38143193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.
    Oyama K; Giugliano RP; Berg DD; Ruff CT; Jarolim P; Tang M; Murphy SA; Lanz HJ; Grosso MA; Antman EM; Braunwald E; Morrow DA
    Eur Heart J; 2021 May; 42(17):1698-1706. PubMed ID: 33760027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated admission N-terminal pro-brain natriuretic peptide level predicts the development of atrial fibrillation in general surgical intensive care unit patients.
    Chokengarmwong N; Yeh DD; Chang Y; Ortiz LA; Kaafarani HMA; Fagenholz P; King DR; DeMoya M; Butler K; Lee J; Velmahos G; Januzzi JL; Lee-Lewandrowski E; Lewandrowski K
    J Trauma Acute Care Surg; 2017 Sep; 83(3):485-490. PubMed ID: 28463935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study.
    Xiao J; Persson AP; Engström G; Johnson LSB
    BMC Cardiovasc Disord; 2021 Mar; 21(1):134. PubMed ID: 33711943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac natriuretic peptides for diagnosis of covert atrial fibrillation after acute ischaemic stroke: a meta-analysis of diagnostic accuracy studies.
    Zhang K; Kamtchum-Tatuene J; Li M; Jickling GC
    Stroke Vasc Neurol; 2021 Mar; 6(1):128-132. PubMed ID: 33004611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B-type natriuretic peptide level after sinus rhythm restoration in patients with persistent atrial fibrillation - clinical significance.
    Wozakowska-Kapłon B; Bartkowiak R; Grabowska U; Janiszewska G
    Kardiol Pol; 2010 Jul; 68(7):781-6. PubMed ID: 20648436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
    Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
    Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation.
    Svennberg E; Henriksson P; Engdahl J; Hijazi Z; Al-Khalili F; Friberg L; Frykman V
    Heart; 2017 Aug; 103(16):1271-1277. PubMed ID: 28255099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac Blood-Based Biomarkers of Myocardial Stress as Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source/Cryptogenic Stroke: A Systematic Review and Meta-Analysis.
    Justo ASDS; Nóbrega SMA; Silva ALA
    J Clin Neurol; 2024 May; 20(3):256-264. PubMed ID: 38171502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial ectopy and N-terminal pro-B-type natriuretic peptide as predictors of atrial fibrillation: a population-based cohort study.
    Kumarathurai P; Mouridsen MR; Mattsson N; Larsen BS; Nielsen OW; Gerds TA; Sajadieh A
    Europace; 2017 Mar; 19(3):364-370. PubMed ID: 27194537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natriuretic peptides for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia--the Find-AF study.
    Wachter R; Lahno R; Haase B; Weber-Krüger M; Seegers J; Edelmann F; Wohlfahrt J; Gelbrich G; Görlitz A; Kermer P; Vollmann D; Hasenfuß G; Gröschel K; Stahrenberg R
    PLoS One; 2012; 7(4):e34351. PubMed ID: 22509292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers for predicting atrial fibrillation: An explorative sub-analysis of the randomised SCREEN-AF trial.
    Schmalstieg-Bahr K; Gladstone DJ; Hummers E; Suerbaum J; Healey JS; Zapf A; Köster D; Werhahn SM; Wachter R
    Eur J Gen Pract; 2024 Dec; 30(1):2327367. PubMed ID: 38497412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
    Bahit MC; Sacco RL; Easton JD; Meyerhoff J; Cronin L; Kleine E; Grauer C; Brueckmann M; Diener HC; Lopes RD; Brainin M; Lyrer P; Wachter R; Segura T; Granger CB;
    Circulation; 2021 Nov; 144(22):1738-1746. PubMed ID: 34649459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of N-terminal pro-B-type natriuretic peptide level in screening for atrial fibrillation in primary health care.
    Ghazal F; Theobald H; Rosenqvist M; Al-Khalili F
    PLoS One; 2019; 14(2):e0212974. PubMed ID: 30807614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
    Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM
    Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum N-terminal-pro-brain natriuretic peptide level and its clinical implications in patients with atrial fibrillation.
    Bai M; Yang J; Li Y
    Clin Cardiol; 2009 Dec; 32(12):E1-5. PubMed ID: 20014208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NT-proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials.
    Werhahn SM; Becker C; Mende M; Haarmann H; Nolte K; Laufs U; Zeynalova S; Löffler M; Dagres N; Husser D; Dörr M; Gross S; Felix SB; Petersmann A; Herrmann-Lingen C; Binder L; Scherer M; Hasenfuß G; Pieske B; Edelmann F; Wachter R
    ESC Heart Fail; 2022 Feb; 9(1):100-109. PubMed ID: 34850596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood-Based Biomarkers to Search for Atrial Fibrillation in High-Risk Asymptomatic Individuals and Cryptogenic Stroke Patients.
    Palà E; Bustamante A; Pagola J; Juega J; Francisco-Pascual J; Penalba A; Rodriguez M; De Lera Alfonso M; Arenillas JF; Cabezas JA; Pérez-Sánchez S; Moniche F; de Torres R; González-Alujas T; Clúa-Espuny JL; Ballesta-Ors J; Ribas D; Acosta J; Pedrote A; Gonzalez-Loyola F; Gentile Lorente D; Ángel Muñoz M; Molina CA; Montaner J
    Front Cardiovasc Med; 2022; 9():908053. PubMed ID: 35859587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.